These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Malignant mesodermal mixed tumor of the uterus--a study of 37 cases]. Zhang WH Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):378-80. PubMed ID: 1664319 [TBL] [Abstract][Full Text] [Related]
9. Effects of irradiation on mixed müllerian tumors of the uterus. Perez CA; Askin F; Baglan RJ; Kao MS; Kraus FT; Perez BM; Williams CF; Weiss D Cancer; 1979 Apr; 43(4):1274-84. PubMed ID: 221087 [TBL] [Abstract][Full Text] [Related]
10. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G; Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158 [TBL] [Abstract][Full Text] [Related]
11. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy. Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465 [TBL] [Abstract][Full Text] [Related]
12. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Aalders JG; Abeler V; Kolstad P Gynecol Oncol; 1984 Jan; 17(1):85-103. PubMed ID: 6693055 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of peritoneal washings in patients with malignant mixed müllerian tumors of the uterus. Geszler G; Szpak CA; Harris RE; Creasman WT; Barter JF; Johnston WW Am J Obstet Gynecol; 1986 Jul; 155(1):83-9. PubMed ID: 3014883 [TBL] [Abstract][Full Text] [Related]
15. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy. Kumar VJ; Nin CY; Kuei LY; Tan KH; Yeo R; Lam PY Int J Gynecol Cancer; 2010 May; 20(4):564-9. PubMed ID: 20686374 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850 [TBL] [Abstract][Full Text] [Related]
17. A clinical-pathologic study of mixed müllerian tumors of the uterus over a 16-year period--the Medical College of Georgia experience. Gallup DG; Gable DS; Talledo OE; Otken LB Am J Obstet Gynecol; 1989 Sep; 161(3):533-8; discussion 538-9. PubMed ID: 2551168 [TBL] [Abstract][Full Text] [Related]
18. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014 [TBL] [Abstract][Full Text] [Related]
19. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital. Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998 [TBL] [Abstract][Full Text] [Related]
20. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]